CV Sciences, Inc. engages in the development, manufacture, and sale of herbal supplements, CBD products and plant-based food products. The company is headquartered in San Diego, California and currently employs 42 full-time employees. The company went IPO on 2018-10-04. The firm develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Mr. Joseph Dowling 2014 'den beri şirketle birlikte olan CV Sciences Inc 'in Chief Executive Officer 'ıdır.
CVSI hissesinin fiyat performansı nasıl?
CVSI 'in mevcut fiyatı $0.03 'dir, son işlem günde 0% azalmış etti.
CV Sciences Inc için ana iş temaları veya sektörler nelerdir?
CV Sciences Inc Consumer products endüstrisine ait ve sektör Consumer Staples 'dir
CV Sciences Inc 'in piyasa değerlemesi nedir?
CV Sciences Inc 'in mevcut piyasa değerlemesi $5.8M 'dir
CV Sciences Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist CV Sciences Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 3 tut, 1 sat ve 0 güçlü sat içermektedir